Records containing: Recurrent Adult Diffuse Mixed Cell Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Trial of Weekly 17-Allylamino-17 Demethoxygeldanamycin
-
CLINICAL_TRIALS study record update · 2013-01-25A Phase I Study of Oblimersen (Genasense™, G3139) in Combination With Gemcitabine in Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-25A Phase I Study Of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin, (17-DMAG) (NSC 707545) In Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase I Study Of Continuous Infusion EMD 121974 In Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275 (NSC 706995, IND 61,198), in Combination With 13-Cis-Retinoic Acid in Metastatic Progressive Cancer.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase I Clinical Trial to Investigate the Correlation Between UGT1A1 Genotype and Irinotecan (CPT-11) Pharmacokinetics and Toxicity in Cancer Patients
-
CLINICAL_TRIALS study record update · 2013-01-23A Phase II Study of Oxaliplatin in Relapsed and Refractory Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-01-14A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Days 1-3 of a 21-Day Cycle in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-11A Phase I Trial of Combination Bryostatin 1 (NSC 339555) and Vincristine in B-Cell Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-10A Phase II Study of Bryostatin 1 and Vincristine in Patients With Low or Intermediate Grade Non-Hodgkin's Lymphoma Progressing or Relapsing After a Prior Autologous Bone Marrow or Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2013-01-10A Phase 1 Study of R-(-)-Gossypol (Ascenta's AT-101) in Combination With Paclitaxel and Carboplatin in Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-07Pharmacokinetic and Phase I Study of Sorafenib (BAY 43-9006, NSC 724772, IND 69896) for Solid Tumors and Hematologic Malignancies in Patients With Hepatic or Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2012-10-19Phase I/II Study of Anti-CTLA-4 Monoclonal Antibody (MDX-010) in B-cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2012-07-09Pilot Study of Mechanical Stimulation for Prevention of Hematopoietic Cell Transplant Associated Bone Density Loss
-
CLINICAL_TRIALS study record update · 2012-03-07INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2011-02-21A Phase II Study of G3139 (Bcl-2 Antisense) And Rituximab in Patients With Recurrent B-cell Non-Hodgkinâs Lymphomas
-
CLINICAL_TRIALS study record update · 2010-12-09A Phase I Study of the Combination of Lenalidomide With the Histone Deacetylase Inhibitor, Vorinostat in Hodgkin and Non Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2010-08-09High-dose Busulfan, High-dose Cyclophosphamide, and Allogeneic Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Lymphoma